These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22619383)

  • 41. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
    Kimmel RJ; Irwin SA; Meyer JM
    Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valproicacid-induced hyperammonemic encephalopathy in the emergency department.
    Pliego Cosano R; Moreno Rosauro JM; Clavero Olmos M
    Emergencias; 2019 Oct; 31(5):364-365. PubMed ID: 31625314
    [No Abstract]   [Full Text] [Related]  

  • 43. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders.
    Lewis C; Tesar GE; Dale R
    Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurotoxicity associated with free valproic acid.
    Mayerhoff DI; Nurenberg J; Shah S; Schleifer SJ
    Am J Psychiatry; 2005 Apr; 162(4):810. PubMed ID: 15800163
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapy of bipolar affective illnesses with valproate. A review of the literature].
    Retzow A; Emrich HM
    Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
    Izadi Firouzabadi L; Geer K; Mead P;
    Postgrad Med J; 2018 Nov; 94(1117):664. PubMed ID: 30397004
    [No Abstract]   [Full Text] [Related]  

  • 50. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].
    Rottach KG; Weiss-Brummer J; Wieland U; Schmauss M
    Nervenarzt; 2000 May; 71(5):401-3. PubMed ID: 10846716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.
    Panikkar GP; Gilman SM
    J Clin Psychiatry; 1999 Aug; 60(8):557-9. PubMed ID: 10485644
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperammonemia due to valproic acid in the psychiatric setting.
    Carr RB; Shrewsbury K
    Am J Psychiatry; 2007 Jul; 164(7):1020-7. PubMed ID: 17606652
    [No Abstract]   [Full Text] [Related]  

  • 55. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 57. Valproate encephalopathy and hyperammonaemia.
    O'Neill M; Dubrey RW; Grocott-Mason RM
    Postgrad Med J; 2002 May; 78(919):316-7. PubMed ID: 12151592
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe acute hyperammonemia after brief exposure to valproate.
    Eubanks AL; Aguirre B; Bourgeois JA
    Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valproate-induced hyperammonemic encephalopathy: a brief review.
    Lewis C; Deshpande A; Tesar GE; Dale R
    Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
    Lin MW; Chang C; Yeh CB; Tai YM; Chang HA; Kao YC; Tzeng NS
    Aust N Z J Psychiatry; 2017 Mar; 51(3):296-297. PubMed ID: 27694641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.